Why International Stocks Could Massively Outperform U.S. Equities in 2026

The article argues that U.S. equities remain investable but may face a relative underperformance phase, citing fallout from the U.S.-Iran conflict, tariffs, and shifting trade alliances. It also highlights AI as a catalyst that could favor production-oriented foreign economies over the U.S. service-heavy economy, with the IMF trimming 2026 U.S. GDP growth to 2.3% from 2.4% and then to 2.1% the following year. The suggested portfolio response is to add international exposure via funds like SCHF or VXUS.

Analysis

The real second-order setup is not simply “international beats U.S.” but that capital may rotate toward regions with more operating leverage to industrial policy, capex, and export re-shoring. If AI remains a productivity tool for manufacturing first, then the beneficiaries are not broad foreign indices alone but the hardware, automation, and power-supply ecosystems embedded in Asia and Europe; that argues for selective exposure rather than passive country beta. The U.S. still has the best balance sheets and innovation premium, but that premium is increasingly expensive relative to the probability of slower nominal growth and weaker trade elasticity over the next 6-18 months.

For the named tickers, NVDA and INTC are not obvious casualties of the article’s thesis, but they face different sensitivities. NVDA’s issue is less demand destruction than multiple compression if the market starts pricing a broader diffusion of AI gains into non-U.S. manufacturing and equipment suppliers; that could cap upside even if earnings stay strong. INTC is a more direct relative winner if governments and corporates accelerate supply-chain diversification and domestic/ally manufacturing buildouts, because its optionality improves when procurement is driven by resilience rather than pure performance.

BAC is the cleanest macro hedge in the list: a weaker U.S. growth backdrop should steepen caution around loan demand and credit quality, but a more defensive positioning in global equities can also support fee-based wealth and market-related revenues. NFLX is the least tied to the thesis, yet it can still benefit from a weaker dollar and from investors rotating toward secular compounders when macro leadership broadens. The main contrarian risk is that this is an overhyped diversification trade: if U.S. rate cuts, AI capex, and dollar softness arrive together, U.S. mega-cap growth can continue to dominate for longer than consensus expects.

Key Decisions for Investors

• Buy SCHF or VXUS on a 4-8 week pullback rather than chasing today; use a 5-7% trailing stop because the trade works only if global growth dispersion widens, not if U.S. exceptionalism reasserts itself.
• Pair long INTC / short NVDA into the next 1-3 months as a relative-value trade on reshoring and procurement diversification; target modest multiple expansion for INTC, but cut the pair if NVDA’s guide implies AI demand remains concentrated in U.S. hyperscale spending.
• Add a small long BAC position only as a macro hedge against a broad U.S. growth deceleration; best entry is after any weakness tied to tariff or geopolitics headlines, with downside limited if credit remains benign and rate vol stays contained.
• Hold NFLX as a defensive growth exposure but do not add aggressively here; upside is better expressed if the dollar weakens materially, so use it as a quality ballast rather than a primary expression of the international rotation.
• Use an options structure on SPY vs. SCHF: buy 3-6 month call spread in SCHF and finance part of it by selling out-of-the-money SPY calls; this monetizes the possibility of foreign outperformance while limiting the risk that U.S. equities keep grinding higher.